e-learning
resources
Berlin 2008
Monday, 06.10.2008
Border patrol: the alveolar barrier in lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mesenchymal stem cell based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysacharride in mice
J. Xu, J. Qu, L. Cao, Y. Sai, C. Chen, L. He, L. Yu (Shanghai, China)
Source:
Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury
Session:
Border patrol: the alveolar barrier in lung injury
Session type:
E-Communication Session
Number:
1674
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Xu, J. Qu, L. Cao, Y. Sai, C. Chen, L. He, L. Yu (Shanghai, China). Mesenchymal stem cell based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysacharride in mice. Eur Respir J 2008; 32: Suppl. 52, 1674
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Does cardiorespiratory polygraphy have a role in non-ventilated children with SMA?
Respiratory evolution of children with Spinal Muscular Atrophy Type 1 under gene therapy
Related content which might interest you:
Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury
Source: Eur Respir J, 59 (1) 2004216; 10.1183/13993003.04216-2020
Year: 2022
Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease
Source: ERS Lung Science Conference 2017
Year: 2017
Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung
Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair
Year: 2012
Successful transplantation of rat mesenchymal stem cells, for the therapy of bleomycin induced lung injury
Source: Annual Congress 2010 - Determinants of acute lung injury and fibrosis
Year: 2010
Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Mesenchymal stem cells prevent early inflammation in a rat model of ventilator induced lung injury
Source: Annual Congress 2011 - Mechanisms of acute lung injury and mesenchymal cell treatment
Year: 2011
Mesenchymal stem cells and recombinant erythropoietin treatment in an experimental sepsis model
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
Electroporation-mediated HGF gene transfer increases mesenchymal stem cell and decreases MMP24 levels in a bleomycin-induced lung injury model.
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells
Source: Eur Respir J 2012; 39: 446-457
Year: 2012
Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating hypoxic signaling
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma
Source: Eur Respir J 2011; 38: 679-687
Year: 2011
Adrenaline stimulated mesenchymal stem cells modulate inflammation in lipopolysaccharide induced lung injury
Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair
Year: 2012
Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011
Electroporation of Hepatocyte growth factor to the lung induces migration of bone marrow mesenchymal stem cells and reduces lung fibrosis
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
Modified mesenchymal stem cells attenuate bleomycin induced lung injury in the rat
Source: Annual Congress 2010 - Stem cells and growth factors in lung injury
Year: 2010
The new-defined mesenchymal stromal/stem cell marker has a protective role in the development of acute lung injury.
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept